Skip to main content
Clinical Trials/IRCT20220803055610N1
IRCT20220803055610N1
Recruiting
Phase 3

Evaluation of the effect of platelet-rich plasma in the treatment of shoulder tendonitis

Tehran University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
200
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pain is the most common symptom.
  • Physical examination findings include pain on movement, weakness and positive tests
  • Diagnosis of rotator cuff tendinopathy with musculoskeletal ultrasound
  • Symptoms have been persistent for more than 3 months and conservative treatment has failed for at least 4 weeks of formal medical treatment and physical therapy.

Exclusion Criteria

  • Full\-thickness rotator cuff tear
  • Current treatment with anticoagulation
  • Steroid injection in the past 6 months in the injuredshoulder
  • Prior PRP treatment to the injured shoulder
  • Bleeding disorders or preoperative platelet countless than 50,000
  • Presence of another disease that may causeshoulder pain and dysfunction as rheumatoidarthritis
  • Prior surgery to the injured shoulder

Outcomes

Primary Outcomes

Not specified

Similar Trials